Skip to main content
. 2022 Nov 11;10(11):2899. doi: 10.3390/biomedicines10112899

Table 2.

CT and 68Ga-NeoBOMB1 lesion detection rates.

Participant Overall Lesion Count (CT and/or 68Ga-NeoBOMB1 PET/CT) CT Positive [n/%] 68Ga-NeoBOMB1 PET/CT Positive [n/%] Overlap [n/%]
01 2 2 (100.0) 2 (100.0) 2 (100.0)
02 1 1 (100.0) 0 (0.0) 0 (0.0)
03 2 2 (100.0) 2 (100.0) 2 (100.0)
04 4 4 (100.0) 1 (25.0) 1 (25.0)
05 8 8 (100.0) 3 (37.5) 3 (37.5)
06 4 2 (50.0) 4 (100.0) 2 (50.0)
07 3 3 (100.0) 0 (0.0) 0 (0.0)
08 4 4 (100.0) 0 (0.0) 0 (0.0)
09 9 6 (66.6) 5 (55.5) 2 (22.2)